Built for biotech, life sciences, and pharma commercial teams
The CRM that treats a KOL, a trial site, and a prescribing physician as different motions.
Biotech commercial work is relationship-driven across KOLs, trial sites, prescribing clinicians, and payer stakeholders. Strkr ships a CRM core shaped around HCP interaction tracking, KOL relationship management, trial site coordination, and compliance-aware activity logging, with HIPAA BAA available on request.
Biotech and pharma commercial organizations run on tooling that was mostly built for the Veeva or IQVIA deployment. Veeva CRM at a mid-sized biotech runs six figures per year with a dedicated admin role plus a yearly consulting contract to keep the configuration from drifting. Smaller biotechs run on Salesforce with heavy custom-object work. Strkr fits as the mid-market option with life-sciences-shaped schema and the compliance posture a regulated commercial organization needs.
Veeva is a six-figure deployment
The dedicated life sciences CRM carries overhead.
A full Veeva CRM deployment at a mid-sized biotech runs $180,000 to $600,000 per year in licenses plus a dedicated admin role plus annual consulting to maintain the configuration. The capability is deep (sampling, formulary, Veeva Vault integration) but the overhead eats commercial operating budget. Strkr sits at a different price point with the 70 to 85 percent of capability most pre-commercial and early-commercial biotechs actually use.
KOL relationship management is tribal
The medical affairs team tracks relationships in their heads.
Key Opinion Leader relationship management at most biotechs runs on tribal knowledge, with the medical science liaison team maintaining their relationships through personal networks and ad-hoc tracking. When an MSL leaves, the relationship transfers to a replacement with significant loss. Strkr ships KOL as a first-class object with influence tier, relationship history, publication tracking, and MSL assignment history logged.
Trial site coordination lives in email
The clinical operations team coordinates sites through Outlook.
Clinical trial site management involves 40 to 240 investigator sites across multiple protocols with coordinated communication, document exchange, and milestone tracking. Most clinical ops teams run this through Outlook with shared drives. Strkr ships trial site as a first-class object tied to the protocol with document status, milestone tracking, and MSL assignment visible on the site card.
HCP interaction compliance
The 10-field activity log that must survive an FDA audit.
Interactions between commercial representatives and HCPs are regulated under the FDCA, the PhRMA Code, and state-level laws (California, Massachusetts, Vermont, Minnesota transparency laws). Every interaction requires logging with specific fields. Strkr ships HCP interaction logging as a workflow with the regulated field set required (interaction type, materials used, meals or education provided, aggregated spend) with the audit log suitable for FDA review.
Formulary tracking is a spreadsheet
Payer coverage status lives in Excel.
Formulary status across payers (preferred tier, non-preferred, prior authorization required, step therapy required, not covered) is a critical commercial signal. Most biotechs track formulary in a quarterly spreadsheet refresh from payer data. Strkr ships formulary as a first-class object tied to the payer with tier status, prior auth requirements, and reimbursement rates.
Sunshine Act reporting is manual
The annual Open Payments report takes weeks.
The federal Sunshine Act (Open Payments) requires manufacturers to report payments to HCPs annually. Most biotechs rebuild the report from HCP interaction logs each year, which takes weeks. Strkr ships the Sunshine Act report as a standard report that aggregates HCP interactions by payment category throughout the year, so the annual filing is a 48-hour effort instead of a six-week project.
The biotech schema
Objects shaped like life sciences commercial work.
Strkr ships a tunable biotech schema with HCP, KOL, Trial Site, Protocol, Payer, and HCP Interaction as first-class objects. The commercial operations director can rename or extend anything. The default lands close to where mid-sized biotechs typically settle.
HCP object
Specialty, practice, affiliation, NPI.
A healthcare provider in Strkr carries NPI, specialty, practice location, hospital affiliation, academic affiliation, prescribing patterns (where accessible through compliant data sources), formulary access, and interaction history. The schema drives the territory alignment and the AI retrieval scope.
KOL object
Influence tier, publication, relationship.
A KOL object tracks the key opinion leader with influence tier (international, national, regional, local), publication record (links to PubMed references), speaking engagements, advisory board participation, and MSL relationship assignment history.
Trial site object
Protocol, PI, status, milestones.
A trial site ties to the protocol with primary investigator, site coordinator, status (identification, feasibility, IRB submission, IRB approved, open to enrollment, enrolling, follow-up, closed), enrollment numbers, document status, and milestone tracking.
Protocol object
Phase, indication, sites, enrollment.
A protocol captures the clinical trial with phase (preclinical, Phase I, Phase II, Phase III, Phase IV, investigator-initiated), indication, protocol number, enrollment target, site count, and status. The protocol drives the trial site cockpit and the KOL engagement for scientific advisory.
Payer object
Formulary tier, prior auth, reimbursement.
A payer object tracks the health plan with coverage decision (preferred tier, non-preferred, not covered), prior authorization requirements, step therapy requirements, utilization management rules, and reimbursement rates. The payer drives market access strategy for the commercial team.
HCP interaction object
Type, materials, meals, aggregated spend.
An HCP interaction logs the compliant engagement with interaction type (sales call, medical science liaison visit, advisory board, speaker program, dinner meeting), materials shared, meals or education provided, aggregated spend, and compliant interaction notes. The log drives the Sunshine Act reporting flow.
How Strkr AI drafts for biotech commercial work
The AI jobs that fit life sciences communication.
Biotech commercial communication requires compliant tone and specific scientific accuracy. Strkr AI drafts with retrieval scope that pulls from the HCP record, KOL publication history, trial site documents, and prior interaction history. AI drafts for regulated commercial communication must be reviewed before send (always).
MSL pre-call briefing
The one-page prep before an HCP visit.
Before an MSL visit Strkr AI drafts a one-page briefing with the HCP publication history, prior interaction history, specialty focus, formulary access, and relevant protocol activities. The MSL reviews five minutes before the visit instead of rebuilding the picture from scratch.
Trial site communication
Routine site coordinator outreach.
For routine trial site communication (document request reminders, milestone status updates, enrollment report requests) Strkr AI drafts the outreach with the protocol context, document status, and recent site interactions. The clinical ops coordinator reviews and sends.
Advisory board follow-up
The post-meeting summary for KOLs.
After an advisory board meeting Strkr AI drafts the follow-up summary with the discussion recap, action items, and the honorarium documentation. The medical affairs director reviews before sending to the KOL panel.
Formulary pursuit communication
The P and T committee submission support.
For pharmacy and therapeutics committee submissions Strkr AI drafts the clinical evidence summary from the protocol publication history and the health economics data. The market access manager reviews extensively given the regulatory sensitivity before any payer submission.
Internal commercial review memo
The territory performance recap.
For internal territory review meetings Strkr AI drafts the performance recap with HCP interaction count, formulary status changes, trial site milestones, and KOL engagement activity. The territory director uses the memo for the monthly team review.
Investigator initiated trial inquiry
The response to a KOL IIT proposal.
When a KOL submits an investigator initiated trial proposal Strkr AI drafts the acknowledgment and the clinical operations review timeline. The medical affairs team reviews before responding, and the response triggers the IIT review workflow in Strkr with routing to clinical, legal, and medical review.
The biotech commercial operating cadence
The views a life sciences team runs weekly.
Strkr ships views shaped around biotech commercial operating cadence. The cards below are the views a commercial operations director, MSL manager, and clinical operations director open on Monday morning.
Territory cockpit
HCP targeting and call plan execution.
The territory cockpit surfaces the sales representative or MSL target HCP list with planned calls, completed calls, next-visit date, and interaction history. The regional manager uses the cockpit for team coaching and performance review.
KOL activity cockpit
Engagement across tier 1 and tier 2 KOLs.
The KOL activity cockpit surfaces every tier 1 and tier 2 KOL with the current engagement cadence, upcoming advisory boards, speaking engagements, and publication activity. The medical affairs leader uses the cockpit for KOL development planning.
Trial site enrollment
Protocol progress by site.
The trial site enrollment view ranks every trial site by enrollment velocity (ahead of target, on target, behind target) with projected final enrollment. Sites behind target trigger a focused site visit workflow.
Formulary status dashboard
Payer coverage across the book.
The formulary status dashboard surfaces every payer by coverage tier (preferred, non-preferred, prior auth, step therapy, not covered). Changes month over month flag yellow. New formulary wins flag green. The market access team uses the dashboard for the quarterly pull-through plan.
Sunshine Act running total
Year-to-date HCP transfer of value.
The Sunshine Act running total surfaces year-to-date transfer of value by HCP, by category (consulting fees, honoraria, meals, travel, education), and by territory. The compliance officer uses the dashboard to flag HCPs approaching caps and territories trending high.
Commercial KPI dashboard
HCP coverage, formulary wins, trial progress.
The commercial KPI dashboard surfaces HCP target coverage percentage, formulary tier changes, trial site enrollment velocity, KOL engagement velocity, and territory performance. The chief commercial officer uses the dashboard for the quarterly executive review.
Head-to-head
Strkr vs Veeva CRM for a biotech commercial team.
Most mid-sized biotechs either run on Veeva CRM (expensive but deep) or Salesforce with custom-object workarounds (cheaper but drift-prone). The comparison below is Strkr biotech posture versus Veeva CRM applied to a similar organization.
Feature
Strkr
Veeva CRM for biotech commercial work
HCP interaction compliance
Workflow with required regulated fields.
Deep. Industry standard.
KOL relationship management
First-class with publication tracking.
Deep via Veeva Link.
Trial site coordination
First-class with protocol tie.
Via Veeva Clinical.
Sunshine Act reporting
Standard report with aggregated spend.
Built-in Open Payments module.
Formulary tracking
First-class object with tier status.
Deep via Veeva Market Access.
Annual cost at mid-size
$29 to $119 per seat per month.
$180,000 to $600,000 per year typical.
Admin configuration overhead
Self-service workflow builder.
Dedicated admin role plus annual consulting.
Open API posture
REST, GraphQL, webhook with HMAC.
Veeva APIs, partner ecosystem gates.
HIPAA BAA availability
Available on request.
Standard for life sciences deployment.
How teams use Strkr
Five biotech commercial playbooks.
The playbooks below are patterns Strkr onboarding sees across pre-commercial and early-commercial biotech deployments.
Pattern A
The 42-person pre-commercial biotech preparing for launch.
A 42-person biotech 18 months before anticipated FDA approval needed to stand up commercial infrastructure. The CRO wanted something between Google Sheets and a full Veeva deployment. Strkr onboarding ran a 22-business-day migration landing the HCP schema, the KOL object, the territory alignment, and the HCP interaction compliance workflow. The team ran its pre-launch field planning in Strkr while deferring the Veeva decision until post-launch when scale demanded it.
Pattern B
The 180-person early-commercial biotech launching a specialty drug.
A 180-person biotech launching a specialty therapy with a 60-rep field force needed CRM in six months. Veeva would have taken that long just to configure. Strkr onboarding ran a 32-business-day migration landing the full field force on Strkr with HCP targeting, interaction compliance, formulary tracking, and the Sunshine Act flow. First-year revenue tracked ahead of plan and the commercial team avoided the Veeva implementation drag.
Pattern C
The 420-person growing biotech running two therapies.
A 420-person biotech ran two commercial products with a shared field force. The existing Salesforce custom-object configuration had drifted across six years of commercial operations. Strkr onboarding ran a 42-business-day migration consolidating both therapy areas into Strkr with therapy-specific HCP targeting and shared field-force operations. The admin burden dropped from a dedicated SFDC admin role to a part-time ops responsibility.
Pattern D
The 85-person CRO coordinating 240 trial sites.
An 85-person contract research organization coordinated clinical trial sites across 14 active protocols with 240 total sites. Strkr onboarding ran a 28-business-day migration landing the protocol, trial site, and investigator schema with milestone tracking and document status visible per site. Site enrollment velocity lifted 18 percent in the first six months because stuck sites surfaced earlier.
Pattern E
The 240-person pharma commercial team running market access.
A 240-person pharma commercial team ran market access across 24 regional payer accounts plus 400 integrated delivery networks. Strkr onboarding ran a 32-business-day migration landing the payer schema with formulary tier tracking, prior auth monitoring, and reimbursement rate tracking. The pull-through planning cycle dropped from quarterly manual spreadsheet rebuild to real-time dashboard review.
Run biotech commercial work on a CRM shaped for life sciences.
Book a 30 minute call. We will walk through the HCP schema, the KOL object, the Sunshine Act flow, and the trial site coordination with your actual therapy area and field force structure.
Does Strkr integrate with Veeva Vault, IQVIA data, or Komodo Health?
Strkr integrates with every major life sciences data and document system through its REST and GraphQL API, outbound webhooks with HMAC signing, and the published OpenAPI spec. For Veeva Vault the typical integration pulls document status and references into Strkr while Vault stays as source of truth for the controlled documents. For IQVIA and Komodo Health prescribing data the integration pulls aggregated prescribing patterns into the HCP record for territory analytics. The engineering sprint runs two to four weeks per integration.
How does Strkr handle 21 CFR Part 11 compliance for regulated workflows?
Strkr audit log captures every record read, record write, and electronic signature event with timestamp, user, action, and record identifier retained per the Part 11 requirement. For regulated workflow steps requiring electronic signature (HCP interaction attestation, Sunshine Act record certification, trial site document review) the workflow includes an explicit electronic signature step with MFA re-confirmation. Validation documentation (IQ, OQ, PQ) is available on request for teams in formal Part 11 validation programs. Strkr sits in the GxP-adjacent space rather than full GxP, which fits most commercial and medical affairs use cases.
Can Strkr handle the Sunshine Act (Open Payments) reporting end to end?
Yes. The HCP interaction object captures the regulated fields (interaction type, materials, meals or education, aggregated transfer of value by category). The Sunshine Act report aggregates year-to-date transfer of value by HCP, by category, and by territory with the format matching the CMS submission template. The compliance officer runs the report quarterly for internal review and annually for the federal submission. For state-level transparency law reporting (California, Massachusetts, Vermont, Minnesota, Connecticut) the admin configures state-specific aggregation views on top of the same interaction data.
What does Strkr cost compared to Veeva CRM or Salesforce Health Cloud?
Strkr runs flat per seat at $29 on Starter, $59 on Pro, and $119 on Scale per user per month, with a 14-day trial. For a 60-rep field force on Scale the monthly spend runs $7,140 for seats plus $49 for AI Enhancement. Veeva CRM typically runs $1,100 to $2,400 per rep per month for the full configuration. Salesforce Health Cloud starts around $300 per user per month and climbs with add-ons. Strkr sits well below the dedicated life sciences CRMs because Strkr is a mid-market CRM with life-sciences-first schema rather than a specialized commercial platform.
How does Strkr handle the HIPAA BAA for prescribing data and patient support programs?
Strkr is HIPAA compliant with a BAA available on request. The BAA covers the typical biotech commercial use cases that touch protected health information: patient support program case tracking, prescribing data analytics where the data includes patient-identifying fields, and medical information inquiry handling where the inquirer references patient cases. The AI calls run with retrieval scope that excludes PHI fields by default, and the admin tunes the scope per use case. The audit log captures every HIPAA-relevant event for the privacy officer file.
What is the compliance posture beyond HIPAA for a regulated commercial team?
Strkr is HIPAA compliant with a BAA available on request, GDPR and CCPA compliant today, and SOC 2 Type II is in progress with a target of 2026-Q4. Integration tokens live in AWS KMS, platform credentials live in AWS Secrets Manager, and the audit log captures every record read and write with retention tunable per tenant to the regulatory ceiling. SSO (SAML and OIDC) is live on Scale tier through Clerk for enterprise identity, MFA with TOTP plus text-based verification is live across all tiers, and Verified Domains are live on Scale tier. For regulated life sciences organizations the Part 11 posture, Sunshine Act workflow, and state transparency law support fit the compliance stack most commercial teams need.
No sales call, no migration consultant, no four-month implementation. Enter your card, get 14 days of the full Pro tier, cancel any time before day 14 with zero charge. Spin up a workspace, import your CSV, and have something useful before lunch.
We use cookies.
Essential cookies keep the site working. If you accept, we also enable Google Analytics
so we can see which pages help and which don't. Reject to opt out entirely. Details in our
Privacy Policy.
